Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -421.46% | -433.65% | 4.43% | 6.79% | 87.62% |
| Total Depreciation and Amortization | -5.29% | -3.06% | -7.12% | -9.43% | -8.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.46% | 14.07% | -70.35% | -66.23% | -1.74% |
| Change in Net Operating Assets | -- | -- | 24.12% | 26.00% | -- |
| Cash from Operations | -195.13% | -197.35% | 3.03% | 5.42% | 140.93% |
| Capital Expenditure | -248.28% | -258.62% | 49.62% | 51.02% | 98.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -248.28% | -258.62% | 46.23% | 47.61% | 98.10% |
| Total Debt Issued | -- | -- | -14.56% | -14.56% | -- |
| Total Debt Repaid | 79.58% | 79.58% | 20.20% | 20.20% | -1,412.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 79.59% | 79.11% | -7.64% | -9.96% | -1,399.02% |
| Foreign Exchange rate Adjustments | -225.00% | -225.00% | -112.23% | -111.64% | 128.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.11% | -3.47% | 2.32% | 4.73% | 48.62% |